跳至主要内容
临床试验/NCT05604001
NCT05604001已完成不适用

In-office Hysteroscopic Laser Ablation for Symptomatic Submucous Uterine Fibroids: Impact on Size and Vascularization.

Ariel University5 个研究点 分布在 3 个国家目标入组 20 人开始时间: 2018年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
5
主要终点
Bleeding

研究概览

简要总结

To evaluate feasibility and efficacy of in-office hysteroscopic ablation of submucous uterine fibroid using diode laser

详细描述

A pilot study was conducted between January 2018 and January 2019 in a tertiary care university hospital. Patients with at least one symptomatic, class 0-2 of FIGO classification, uterine fibroid of ≤ 7cm in size were eligible for inclusion. Evaluation of the changes in fibroid size and vascularity was performed using 3D Doppler ultrasonography. Vaporization of the fibroid core was conducted using a 1470nm wavelength diode laser inserted through the hysteroscope's working channel. Primary outcome was the evaluation of the fibroid volume before and at 2 months after the procedure.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • symptomatic patients without desire of future fertility (symptoms included heavy menstrual bleeding, abdominal discomfort, bulk symptoms such as urinary frequency, pelvic pressure and constipation),
  • grade 0-2 (FIGO classification) ≤ 7cm fibroids with evident vascularity seen by 3D-DS compared to its adjacent myometrial tissue

排除标准

  • intramural fibroids (FIGO class 3 or more),
  • >2 submucosal fibroids,
  • pelvic inflammatory disease,
  • known gynecologic malignancy,
  • severe cervical stenosis,
  • pregnancy
  • desire of future fertility,
  • previous cervical surgery

结局指标

主要结局

Bleeding

时间窗: before the procedure and at 3 months follow up visit

improvement of the heavy menstrual bleeding

次要结局

  • fibroid volume reduction(before the procedure and at 3 months follow up visit)
  • changes on the myoma vascularity(before the procedure and at 3 months follow up visit)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sergio Haimovich

Director of the Gynecology Department at the Laniado Hospital

Ariel University

研究点 (5)

Loading locations...

相似试验